Brief Title
Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer
Official Title
Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer
Brief Summary
Older woman with ovarian cancer have a worse prognosis compared to younger patients. However,
the reason is not known. Currently, the standard of care is to evaluate younger and older
patients with cancer the same way. However, older patients with cancer often have more
complicated issues to manage. For example, older patients often have other medical problems,
take more medications, and be dependent on others for help and transportation. Too often, the
medical team is unaware of these issues which can effect the patients care.
The purpose of this study is to apply a set of questions designed specifically for patients
with cancer who are older than 65 years of age. These questions are called a geriatric
assessment.
The investigators want to better understand which older patients with ovarian cancer will be
able to tolerate the chemotherapy and surgery and why. This study will also see if a
telephone call from a nurse who specializes in caring for older patients will improve patient
care. This study will determine how feasible it is to perform geriatric assessments and
telephone calls in patients with ovarian cancer.
Study Type
Observational
Primary Outcome
feasibility of a geriatric assessment (GA)
Secondary Outcome
estimate if the cancer-specific GA parameters will predict toxicity.
Condition
Ovarian Cancer
Intervention
geriatric assessment and telephone call from nurse
Study Arms / Comparison Groups
patient will receive a phone call from nurse
Description: The proposed study will be a prospective longitudinal feasibility study of 50 older adults with a recent diagnosis of stage II, III or IV ovarian cancer who will receive standard first line chemotherapy and surgery over approximately a six-month period. Half of the 50 patients receive a weekly telephone call from geriatric nurse practitioner (NP); the remaining 25 patients would receive standard oncology care alone (randomization).
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Behavioral
Estimated Enrollment
50
Start Date
November 2011
Completion Date
November 2023
Primary Completion Date
November 2023
Eligibility Criteria
Inclusion Criteria:
- Patients must be > or = to age of 65. Will receive platinum-based chemotherapy and
surgery at MSKCC for stage II-IV ovarian, fallopian tube or peritoneal cancer.
- Pathologic confirmation or high suspicion based on Ca125 level and/or radiologic
evidence of ovarian, fallopian tube or peritoneal cancer.
- Able to understand English.
- Be able to provide informed consent.
Exclusion Criteria:
- Enrolled on a phase I trial.
Gender
Female
Ages
65 Years - N/A
Accepts Healthy Volunteers
No
Contacts
William Tew, MD, ,
Location Countries
United States
Location Countries
United States
Administrative Informations
NCT ID
NCT01471483
Organization ID
11-164
Responsible Party
Sponsor
Study Sponsor
Memorial Sloan Kettering Cancer Center
Study Sponsor
William Tew, MD, Principal Investigator, Memorial Sloan Kettering Cancer Center
Verification Date
December 2022